Editorial: Probiotic bacteria-derived effector molecules and their impact on the host in health and disease

. 2022 ; 13 () : 1089461. [epub] 20221129

Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium electronic-ecollection

Typ dokumentu úvodníky

Perzistentní odkaz   https://www.medvik.cz/link/pmid36523843
Komentář

Editorial on the Research Topic Probiotic bacteria-derived effector molecules and their impact on the host in health and disease PubMed

Zobrazit více v PubMed

Lebeer S., Bron P. A., Marco M. L., Van Pijkeren J. P., O'Connell Motherway M., Hiil C., et al. . (2018). Identification of probiotic effector molecules: present state and future perspectives. Curr. Opin. Biotechnol. 49, 217–223. 10.1016/j.copbio.2017.10.007 PubMed DOI

Pyclik M., Srutkova D., Schwarzer M., Gorska S. (2020). Bifidobacteria cell wall-derived exo-polysaccharides, lipoteichoic acids, peptidoglycans, polar lipids, and proteins - their chemical structure and biological attributes. Int. J. Biol. Macromol. 147, 333–349. 10.1016/j.ijbiomac.2019.12.227 PubMed DOI

Tlaskalova-Hogenova H., Stěpánková R., Kozáková H., Hudcovic T., Vannucci L., Tučková L., et al. . (2011). The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell. Mol. Immunol. 8, 110–120. 10.1038/cmi.2010.67 PubMed DOI PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...